Clinical Trials Browser

Epstein-Barr Virus Infections × Matrix-M × 1 year × Clear all

NCT05683834 2025-11-21

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

Phase 1/2 Active not recruiting

Herpes Simplex, Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT04645147 2025-07-17

Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection

Phase 1 Active not recruiting

Infectious Mononucleosis, Epstein-Barr Virus Infections